- Home
- / Revelation Biosciences
Revelation Biosciences
Stock Price
$0.8
2024-10-29
Market Capitalization
$3.1 M
2024-10-29
Revelation Biosciences Summary
Company Summary
- Overview
- Revelation Biosciences is a clinical-stage life sciences company. It focuses on the development of immunologic-based therapies for the prevention and treatment of disease.
- Type
- Public
- Status
- Active
- Founded
- 2020
- HQ
- San Diego, CA, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
Chester Zygmont, Chief Financial Officer
Robin Marsden, Vice President, Biology
LocationsView all
1 location detected
San Diego, CA HQ
United States
La Jolla Centre I, 4660 La Jolla Village Dr
Revelation Biosciences Financials
Summary Financials
- Net income (Q1, 2026)
- ($8.7M)
- Cash (Q1, 2026)
- $14.1M
- EBIT (Q1, 2026)
- ($3.1M)
- Enterprise value
- ($10.2M)